Analytical Data
-
Gene name
S100A6
- Application
-
Alternative Names
S100-A6; 2A9; 5B10; CABP; CACY; PRA; MLN 4; Calcyclin; Growth factor-inducible protein 2A9; Prolactin receptor-associated protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P06703
-
Expression Region
Met1~Gly90
-
Molecular Weight
16kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
S100A10 is a member of the S100 family of calcium-binding proteins, which play critical roles in various cellular processes, including cell proliferation, differentiation, and motility. Research has indicated that S100A10 is involved in the regulation of key physiological functions and has been implicated in several pathological conditions, such as cancer, inflammation, and neurodegenerative diseases. Its ability to interact with numerous target proteins highlights its importance in cellular signaling pathways. In cancer biology, S100A10 has been associated with tumor progression and metastasis, making it a potential biomarker and therapeutic target. The recombinant production of S100A10 protein enables detailed studies of its structure-function relationships and interactions with other proteins, facilitating the development of S100A10-based diagnostic tools and treatments. Understanding the molecular mechanisms by which S100A10 exerts its effects could uncover novel therapeutic strategies for diseases where S100A10 is dysregulated. Given its multifaceted roles and relevance in various research fields, the study of S100A10 recombinant protein remains a significant focus in the realms of biochemistry, cell biology, and medical research, potentially leading to breakthroughs in our understanding of its contributions to health and disease.
